Jared L. Stringham

Jared Stringham practices intellectual property law, with an emphasis on Hatch-Waxman litigation in the pharmaceutical, biotechnology, and chemical arts. Jared has experience in U.S. District Court litigation, appeals before the U.S. Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board. His work covers a wide range of products and technologies, including drugs and treatments for renal disease, Alzheimer's disease, immunosuppression, cancers and non-malignant tumors, hypertension, and heart failure. Before joining Venable, Jared spent his entire career in private practice at Fitzpatrick, Cella, Harper & Scinto.